Viewing Study NCT00091832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-01-06 @ 9:03 PM
Study NCT ID: NCT00091832
Status: COMPLETED
Last Update Posted: 2014-01-28
First Post: 2004-09-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Metastases View
None Bone Metastases in Subjects With Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Cancer View